Atıf İçin Kopyala
Altay S., Yildirimturk O., Cakmak H. A., Askin L., SİNAN Ü. Y., BEŞLİ F., ...Daha Fazla
ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, sa.5, ss.353-361, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
17
Sayı:
5
-
Basım Tarihi:
2017
-
Doi Numarası:
10.14744/anatoljcardiol.2016.7472
-
Dergi Adı:
ANATOLIAN JOURNAL OF CARDIOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.353-361
-
Anahtar Kelimeler:
new oral anticoagulants, atrial fibrillation, embolic complication, bleeding, ATRIAL-FIBRILLATION, STROKE INCIDENCE, CASE-FATALITY, RISK-FACTORS, MORTALITY, WARFARIN, THROMBOEMBOLISM, TRENDS
-
Ondokuz Mayıs Üniversitesi Adresli:
Evet
Özet
Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic and clinical parameters and bleeding and/or embolic events under NOACs treatment were analyzed.